Drawing for ERO>>

USPTO serial 90658317

ERO>>

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JACKSON, MARISSA SHARPE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ERO>>?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Hannah L. Cannom

Hannah L. Cannom WALKER STEVENS CANNOM LLP500 MOLINO STREET, SUITE 118LOS ANGELES, CA 90013United States

Goods and services

ClassDescriptionStatusFirst use
010Medical clothing, namely, surgical scrub tops and surgical scrub pantsACTIVE—
025Scrub tops and scrub pants for non-surgical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 10, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 10, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 23, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 23, 2024EX5GSOU EXTENSION 5 GRANTED—
Sep 23, 2024EXT5SOU EXTENSION 5 FILED—
Sep 23, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 23, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 22, 2024EX4GSOU EXTENSION 4 GRANTED—
Mar 22, 2024EXT4SOU EXTENSION 4 FILED—
Mar 22, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 26, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 25, 2023EX3GSOU EXTENSION 3 GRANTED—
Oct 22, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Oct 22, 2023TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Oct 22, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Oct 22, 2023PETGPETITION TO REVIVE-GRANTED—
Oct 22, 2023PROATEAS PETITION TO REVIVE RECEIVED—
Sep 22, 2023EXT3SOU EXTENSION 3 FILED—
Jun 15, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 14, 2023EX2GSOU EXTENSION 2 GRANTED—
Jun 12, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 26, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Apr 25, 2023TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Apr 25, 2023PETGPETITION TO REVIVE-GRANTED—
Apr 25, 2023PROATEAS PETITION TO REVIVE RECEIVED—
Apr 24, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 24, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 22, 2023EXT2SOU EXTENSION 2 FILED—
Sep 23, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 21, 2022EX1GSOU EXTENSION 1 GRANTED—
Sep 21, 2022EXT1SOU EXTENSION 1 FILED—
Sep 21, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 22, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 21, 2021PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 21, 2021ALIEASSIGNED TO LIE—
Dec 21, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 20, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Dec 20, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 20, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 20, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 13, 2021DOCKASSIGNED TO EXAMINER—
Jul 29, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 28, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 23, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance